Non-peptide

Seltorexant

Also known as

JNJ-42847922 · MIN-202 · 2-SORA · selective OX2 antagonist · seltorexant 20 mg

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	An investigational oral small molecule, also called JNJ-42847922 or MIN-202, that blocks orexin-2 wakefulness signaling. It is not a sleep peptide.
Product distinction	Community tablets, powders and solutions have unverified identity and strength. Their milligrams are not DSIP micrograms, and trial medicine does not authenticate online products.

Notes

Seltorexant is an investigational oral compound discussed for falling asleep and staying asleep. Some users describe a major sleep benefit; others report brief effects, little improvement or groggy mornings. The practical distinction is whether sleep onset, overnight continuity or next-day functioning actually changed.

An oral small molecule, not a sleep peptide. JNJ-42847922 and MIN-202 are names for seltorexant. It targets orexin-2, part of the brain’s wakefulness signaling system. Blocking that signal can make sleep easier. It differs from zolpidem’s mechanism and from drugs that block both orexin receptors; selectivity does not guarantee a cleaner morning. Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial (Official context · Accessed 2026-09-30)

Community products and trial medicine are different evidence. Reports involve swallowed tablets, powder or solutions labeled seltorexant. Their identity and strength are unverified. This card’s milligrams are not DSIP micrograms.

Insomnia trial amounts were fixed comparison groups. Oral 5, 10 or 20 mg was given nightly for 14 days; 10 and 20 mg improved selected sleep measures through night 13. Sleepiness and heart-rhythm-related discontinuations were reported. This trial does not verify an online product. Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial (Official context · Accessed 2026-09-30)

Source context — Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial: Industry-funded controlled trial without psychiatric comorbidity; cannot validate online products or community-selected quantities. PMC access returned reCAPTCHA. PubMed and JAMA share one original study allowance.

What people notice

Falling asleep versus staying asleep	Some describe major sleep benefit; others fall asleep more easily without fixing restless sleep or early waking. Those are different outcomes.
Wearable reports	One three-night 10 mg log reported more hours and scores above 95. A separate 10–25 mg account found unchanged scores and substantial grogginess; scores do not establish better deep sleep.
Morning effects	Headaches can occur even in a 5 mg account. Other reports include fogginess or worsened insomnia; low amounts do not guarantee a clear morning.

Notes

Falling asleep, fewer awakenings, or both. In one discussion, users described easier sleep onset but little improvement in restless sleep or early waking. Another described a major sleep benefit after previously favoring DSIP. These accounts address different problems; faster sleep onset need not mean more hours or a refreshed morning. Have you tried the seltorexant yet? (Community discussion · Accessed 2026-09-30)

Sleep continuity and wearable scores. Biohacking logs describe fewer brief awakenings and better efficiency before longer nights. One 10-mg, three-night log reported scores above 95 and more hours; a separate 10–25-mg account reported unchanged scores and substantial grogginess. Neither device numbers nor enthusiasm establish cause or improved deep sleep.

Low amounts are not automatically free of adverse effects. Morning headaches occur in the 5-mg account as well as the middle-night-use post. Other 20–25-mg logs include fogginess. A sparse separate reply reports worsened insomnia; another commenter doubts it, without resolving what happened. These reports cannot establish incidence or causation. seltorexant reports (Community discussion · Accessed 2026-09-30) · Has anybody had any side effects from seltorexant at all? (Community discussion · Accessed 2026-09-30)

Source context — Have you tried the seltorexant yet?: Self-selected accounts; unspecified seltorexant quantities, product identity and background therapies. Relative dates differ across crawler versions; no exact comment dates inferred.

Source context — seltorexant reports: Products/doses unverified; no denominator or sleep study. 5-mg follow-up is one account. Half-life is secondhand development-number discussion, not community measurement. The full-dropper report is too uncertain for mg conversion.

Source context — Has anybody had any side effects from seltorexant at all?: One sparse account; no quantity, duration, product testing, dechallenge or causal confirmation. Skepticism is an opinion, not a refutation.

Doses people talk about

Bedtime logs	5–10 mg orally per administration is the circulated bedtime band, usually in nightly experiments. One comparison favored 5 mg over 10 or 15 mg; that is not a dose-selection rule.
Separate higher accounts	One 20 mg account described brief benefit; another reached 40 mg with inconsistent onset. Separate 15–25 mg reports describe grogginess. These are not recommended ladder steps.
Unknown concentration	One report of 1 mL lacks concentration and cannot be converted into a milligram amount.

Notes

5–10 mg orally in biohacking logs. The circulated bedtime band is a reported amount per administration, usually in nightly experiments. One comparison favored 5 mg, found no added benefit at 10 or 15 mg, and described worse sleep at 15 mg. It is not a dose-selection rule.

20 mg and experiments up to 40 mg are separate accounts. One commenter reported benefit at 20 mg lasting briefly. Another reached 40 mg with inconsistent sleep onset. A third used 20 mg plus lemborexant, confounding maintenance. Other 15–25-mg reports describe grogginess; these are not steps on a recommended ladder. Users of seltorexant pls guide (Community discussion · Accessed 2026-09-30)

Reported milliliters cannot be converted here. A commenter reported no benefit from 1 ml without a concentration. That is not evidence for a particular milligram amount or daily total. Users of seltorexant pls guide (Community discussion · Accessed 2026-09-30)

Source context — Users of seltorexant pls guide: Distinct authors are not corroborating one dose response. Route inferred from ingested solution context where present; exact frequency missing. Combination confounds maintenance. Relative dates stale, not called a new September thread.

Half-life, onset & duration

Felt onset	Bedtime accounts describe about 20–40 minutes and habits around 30 minutes before bed. These are reported experiences, not a proven interval.
Felt duration	One 20 mg user estimated 2–3 hours of benefit; a separate 5 mg user reported 7–8 hours asleep with morning headaches. Sleep length is not elimination half-life.
Half-life	Healthy-subject morning-dose research reported 2–3 hours. Sedation and mild attention changes at four hours in some groups contradict blanket four-hour-clearance claims.
Blood peak	0.5–1.5 hours in that healthy-subject morning-dose study, separate from bedtime onset or remaining sleep time.

Notes

20–40 minutes appears in biohacking bedtime accounts. About 30 minutes before bed is also circulated. These are reported timing habits and experiences, not a proven bedtime interval or the same thing as a peak blood level.

A brief effect and a full night both appear. One 20-mg user estimated 2–3 hours of benefit. In a separate thread, one 5-mg user reported 7–8 hours asleep, with morning headaches; their follow-up disclosed no other substance or tracker. These describe felt benefit and sleep length, not bodily half-life. Users of seltorexant pls guide (Community discussion · Accessed 2026-09-30) · seltorexant reports (Community discussion · Accessed 2026-09-30)

Measured blood timing is separate from the sleep reports. Healthy-subject morning dosing produced a 0.5–1.5-hour blood-level peak and 2–3-hour half-life. Sedation ratings and mild attention changes appeared at four hours in some groups, contradicting blanket four-hour-clearance claims. Multiple daytime administration of JNJ-42847922 in healthy subjects (Official context · Accessed 2026-09-30)

Middle-night use is also disputed. One poster found it helpful for getting back to sleep but had morning headaches. A long-COVID commenter found little rescue benefit while discussing other sleep medicines. Neither supplies a reliable remaining sleep window or evidence for repeat administration. seltorexant reports (Community discussion · Accessed 2026-09-30) · Sleep fragmentation: orexin-system discussion (Personal report · Accessed 2026-09-30)

Source context — Multiple daytime administration of JNJ-42847922 in healthy subjects: Small healthy-subject daytime study, industry affiliations; not a bedtime effect-duration study or driving assessment. PubMed open returned no usable body; publisher abstract supplied actual evidence.

Source context — Sleep fragmentation: orexin-system discussion: Long-COVID context and other sleep medicines; no seltorexant dose. Does not establish a long-COVID treatment, mechanism or a rescue regimen.

Cycles people discuss

Nightly or occasional use	Reports include three-night and seven-night logs plus longer nightly and occasional experiments. No standard time-on/time-off calendar emerges.
Tolerance and stopping	Available follow-up does not establish tolerance, no rebound, no withdrawal or sustained long-term benefit. A short half-life does not settle these questions.

Notes

Three nights, seven nights, and longer nightly experiments. Logs include 10 mg across three nights and a separate 20-mg, seven-night account claiming improved deep and REM sleep. Nightly testing and occasional use both feature in discussion; no standard time-on/time-off calendar emerges.

Stopping, tolerance and long-term use remain unsettled. Questions about tolerance exceed the follow-up available. A short half-life does not prove next-night baseline, no rebound, no withdrawal or indefinitely sustained benefit. Trial blocks are separate supporting context.

Stacks

Sleep add-ons	Magnesium glycinate, glycine, DSIP, pinealon and epitalon appear in discussions. L-theanine pairings are commercially promoted; better scores do not validate sedating combinations.
Other orexin drugs	One 20 mg report also used lemborexant, so maintenance benefit cannot be assigned to seltorexant. Comparisons or switching between sleep drugs are not proof of safe combinations.

Notes

Other substances complicate both benefit and impairment. Stack discussion includes magnesium glycinate, glycine, DSIP, pinealon, epitalon and commercially promoted L-theanine pairings. Late caffeine also features as a reason for remaining wired. Combining sedating agents cannot be treated as validated by a better sleep score.

Post and visible comments lines 21–83: drippysoap underwhelmed; Apart-Atmosphere1860 one ml without concentration; merhaba81 up to 40 mg, faster/brief and inconsistent onset; isyoucrazyson 20 mg lasting 2–3 hours; MeanGur9932 20 mg with lemborexant afterward. Users of seltorexant pls guide (Community discussion · Accessed 2026-09-30)

Other sedatives: Comparisons and switches involving zolpidem do not establish safe combined use. Better sleep scores cannot validate a sedating combination. [community]

Watch for

Next-day impairment	Headaches, grogginess and fog appear in accounts. Short half-life does not establish morning driving safety or a safe remaining sleep window after middle-night use.
Interactions	A sponsor protocol excluded important CYP3A4/CYP2C9 modifiers and concentrated grapefruit juice. Those study precautions are not a complete interaction guide.
Underlying sleep problems	Sedation does not establish treatment of apnea or a blocked nose. Product contents, pregnancy safety and long-term unsupervised use remain unresolved.
Trial tolerability	A 14-day insomnia trial reported sleepiness and heart-rhythm-related discontinuations. Its controlled comparison does not verify a community product or guarantee tolerability.

Notes

Sleep quality is bigger than a sedative effect. Community cautions distinguish sleep from treating apnea or a blocked nose. Unverified product contents, pregnancy safety and long-term unsupervised use are unresolved here; a short half-life is not evidence of morning driving safety. Multiple daytime administration of JNJ-42847922 in healthy subjects (Official context · Accessed 2026-09-30)

Interaction precautions extend beyond sleep stacks. A sponsor protocol excluded important modifiers of CYP3A4 and CYP2C9, enzymes involved in processing drugs, and listed concentrated grapefruit juice. These study precautions are not a complete interaction guide. MDD3002 protocol amendment 2 (Official context · Accessed 2026-09-30)

Source context — MDD3002 protocol amendment 2: Publicly posted 2021 sponsor protocol is a study rule, not current product labeling or a quantified interaction experiment. No claim that every serving of grapefruit has equal effect.

Full notes

What Seltorexant actually is

An oral small molecule, not a sleep peptide. JNJ-42847922 and MIN-202 are names for seltorexant. It targets orexin-2, part of the brain’s wakefulness signaling system. Blocking that signal can make sleep easier. It differs from zolpidem’s mechanism and from drugs that block both orexin receptors; selectivity does not guarantee a cleaner morning. Official context
Community products and trial medicine are different evidence. Reports involve swallowed tablets, powder or solutions labeled seltorexant. Their identity and strength are unverified. This card’s milligrams are not DSIP micrograms. Community

What people hope to get from it

Falling asleep, fewer awakenings, or both. In one discussion, users described easier sleep onset but little improvement in restless sleep or early waking. Another described a major sleep benefit after previously favoring DSIP. These accounts address different problems; faster sleep onset need not mean more hours or a refreshed morning. Reddit / r/NooTopics
Sleep continuity and wearable scores. Biohacking logs describe fewer brief awakenings and better efficiency before longer nights. One 10-mg, three-night log reported scores above 95 and more hours; a separate 10–25-mg account reported unchanged scores and substantial grogginess. Neither device numbers nor enthusiasm establish cause or improved deep sleep. Community

Doses people discuss

5–10 mg orally in biohacking logs. The circulated bedtime band is a reported amount per administration, usually in nightly experiments. One comparison favored 5 mg, found no added benefit at 10 or 15 mg, and described worse sleep at 15 mg. It is not a dose-selection rule. Community Community
20 mg and experiments up to 40 mg are separate accounts. One commenter reported benefit at 20 mg lasting briefly. Another reached 40 mg with inconsistent sleep onset. A third used 20 mg plus lemborexant, confounding maintenance. Other 15–25-mg reports describe grogginess; these are not steps on a recommended ladder. Reddit / r/NooTopics Community
Reported milliliters cannot be converted here. A commenter reported no benefit from 1 ml without a concentration. That is not evidence for a particular milligram amount or daily total. Reddit / r/NooTopics

Half-life: what the number means

Roughly 1.5–3 hours circulates in forum comparisons. That is a secondhand claim, not a blood measurement by users. Human development research supplies the separate 2–3-hour value below. Half-life means the amount falls by half, not that all effects end then; the forum claim of complete clearance by ten hours is too absolute. Reddit / r/NooTopics

Onset: falling asleep

20–40 minutes appears in biohacking bedtime accounts. About 30 minutes before bed is also circulated. These are reported timing habits and experiences, not a proven bedtime interval or the same thing as a peak blood level. Community

Duration: staying asleep

A brief effect and a full night both appear. One 20-mg user estimated 2–3 hours of benefit. In a separate thread, one 5-mg user reported 7–8 hours asleep, with morning headaches; their follow-up disclosed no other substance or tracker. These describe felt benefit and sleep length, not bodily half-life. Reddit / r/NooTopics Reddit / r/NooTopics
Middle-night use is also disputed. One poster found it helpful for getting back to sleep but had morning headaches. A long-COVID commenter found little rescue benefit while discussing other sleep medicines. Neither supplies a reliable remaining sleep window or evidence for repeat administration. Reddit / r/NooTopics Personal report

Cycles and repeated use

Three nights, seven nights, and longer nightly experiments. Logs include 10 mg across three nights and a separate 20-mg, seven-night account claiming improved deep and REM sleep. Nightly testing and occasional use both feature in discussion; no standard time-on/time-off calendar emerges. Community Community
Stopping, tolerance and long-term use remain unsettled. Questions about tolerance exceed the follow-up available. A short half-life does not prove next-night baseline, no rebound, no withdrawal or indefinitely sustained benefit. Trial blocks are separate supporting context. Community

Limits and things users notice

Low amounts are not automatically free of adverse effects. Morning headaches occur in the 5-mg account as well as the middle-night-use post. Other 20–25-mg logs include fogginess. A sparse separate reply reports worsened insomnia; another commenter doubts it, without resolving what happened. These reports cannot establish incidence or causation. Reddit / r/NooTopics Community Reddit / r/NooTopics
Other substances complicate both benefit and impairment. Stack discussion includes magnesium glycinate, glycine, DSIP, pinealon, epitalon and commercially promoted L-theanine pairings. Late caffeine also features as a reason for remaining wired. Combining sedating agents cannot be treated as validated by a better sleep score. Community
Interaction precautions extend beyond sleep stacks. A sponsor protocol excluded important modifiers of CYP3A4 and CYP2C9, enzymes involved in processing drugs, and listed concentrated grapefruit juice. These study precautions are not a complete interaction guide. Official context
Sleep quality is bigger than a sedative effect. Community cautions distinguish sleep from treating apnea or a blocked nose. Unverified product contents, pregnancy safety and long-term unsupervised use are unresolved here; a short half-life is not evidence of morning driving safety. Community Official context

What human studies add

Measured blood timing is separate from the sleep reports. Healthy-subject morning dosing produced a 0.5–1.5-hour blood-level peak and 2–3-hour half-life. Sedation ratings and mild attention changes appeared at four hours in some groups, contradicting blanket four-hour-clearance claims. Official context
Insomnia trial amounts were fixed comparison groups. Oral 5, 10 or 20 mg was given nightly for 14 days; 10 and 20 mg improved selected sleep measures through night 13. Sleepiness and heart-rhythm-related discontinuations were reported. This trial does not verify an online product. Official context
Depression investigation has several distinct settings. An adjunctive trial studied once-daily 10, 20 and 40 mg with existing antidepressants and a six-week outcome. J&J reported positive MDD3001 results, whereas MDD3005’s 20-mg, 26-week comparison did not establish superiority over quetiapine XR, despite less sleepiness and weight gain. Sponsor reports are commercial context. Official context Official context Official context
Investigational does not mean adjunct-only forever. J&J also lists a phase 3 monotherapy study begun in 2026. A study listing establishes neither a stand-alone treatment benefit nor approval. Official context

How the discussions fit together

The useful split is the sleep problem being measured. A commenter who struggles to fall asleep may value a fast effect. Someone already falling asleep but waking early may call the same compound ineffective. Their descriptions address different sleep problems; neither establishes the response of most users. Reddit / r/NooTopics
Comparisons are personal, and more can disappoint. DSIP comparisons range from replacement enthusiasm to mixed results. The wearable dose-comparison log favored 5 mg over higher amounts, while other reports favored 20 mg. Unchanged scores, short benefit and groggy mornings belong beside positive accounts, rather than being explained away as the wrong dose. Community Community
A strong mechanism story is still a hypothesis about experience. The appeal of selective orexin-2 blockade is quieter wakefulness with less morning fog. Posts comparing other orexin drugs also caution that half-life alone does not explain how they feel. Seltorexant’s mixed accounts keep that hoped-for tradeoff open. Reddit / r/NooTopics